Spectrum Neuroscience and Treatment Institute

Spectrum Neuroscience and Treatment Institute in Manhattan, New York offers intranasal esketamine (Spravato) for patients with treatment-resistant depression, prescribed alongside an antidepressant. The clinic provides a comprehensive Spravato program that includes an in-depth consultation, an individualized esketamine dose and treatment schedule, and selection of the optimal companion antidepressant.

An interdisciplinary practice combining clinical neuroscience with evidence-based medicine, Spectrum also offers TMS, which is FDA-approved for both treatment-resistant depression and OCD, as a non-invasive option using precisely targeted magnetic pulses.

Additional services include psychopharmacology, medication management, therapy with specialized expertise in autism spectrum disorder and OCD, psychological testing, psilocybin-assisted psychotherapy through a clinical trial, and family and sibling support, all delivered through personalized, compassionate care.